EUVIMEDEUVIMED entdecken
KommentarOpen Access · CC BY 4.0

Chemogenetics reveals a surprising role for GPR18 signaling in immunometabolic regulation of β cell activity

Xianglin Huang, Bryan L Roth

Journal of Clinical Investigation · 16.11.2026 · 136 (22)

DOI: 10.1172/jci212477 ↗

Kurz gefasst

Kommentar in der Zeitschrift Journal of Clinical Investigation, online erschienen am 16.11.2026. Verfasst von Xianglin Huang und 1 weiteren Autor:innen. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Insulin-Secreting Cells, Signal Transduction, Macrophages. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic islet macrophages are important immunometabolic regulators of β cell function, particularly in obesity-associated type 2 diabetes. Previous studies have established that pancreatic islet macrophages communicate with β cells through either the release of cytokines and growth factors, or direct cell–cell contact. In this issue of the JCI , Singh et al. used chemogenetics to identify a Gq/AMPK pathway that remodels sphingolipid metabolism. This pathway links macrophages to β cells through a CD36-dependent mechanism that reduces insulin secretion. Surprisingly, the orphan GPCR GPR18 was identified as the receptor that engages this pathway. These findings expand our understanding in macrophage–β cell communication and identify GPR18 as a potential therapeutic target for type 2 diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, G-Protein-CoupledInsulin-Secreting CellsSignal TransductionMacrophagesHumansAnimalsChemogeneticsDiabetes Mellitus, Type 2InsulinInsulin SecretionCell CommunicationMice

Substanzen

Receptors, G-Protein-CoupledGPR18 protein, humanInsulin

Zitieren

APA

Huang, X., & Roth, B. L. (2026). Chemogenetics reveals a surprising role for GPR18 signaling in immunometabolic regulation of β cell activity. Journal of Clinical Investigation, 136(22). https://doi.org/10.1172/jci212477

Vancouver

Huang X, Roth BL. Chemogenetics reveals a surprising role for GPR18 signaling in immunometabolic regulation of β cell activity. Journal of Clinical Investigation. 2026;136(22). doi:10.1172/jci212477

BibTeX
@article{Huang2026,
  author = {Huang, Xianglin and Roth, Bryan L},
  title = {Chemogenetics reveals a surprising role for GPR18 signaling in immunometabolic regulation of β cell activity},
  journal = {Journal of Clinical Investigation},
  year = {2026},
  volume = {136},
  number = {22},
  doi = {10.1172/jci212477}
}
Kostenlos starten →